Clinical Trial Update: Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update assessing tebentafusp in combination with radioembolization for metastatic uveal melanoma, including liver metastases, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Radioembolization with yttrium-90 microspheres (yttrium-90 microspheres)
• Tebentafusp (tebentafusp)

Snippet

Sponsor: University of Miami | Conditions: Metastatic Uveal Melanoma, Metastatic Uveal Melanoma in the Liver | Phase 2 | Status: RECRUITING